血压平颗粒治疗妊娠高血压疾病临床研究  

Clinical investigation of Xueyaping granules on pregnancy-induced hypertension

在线阅读下载全文

作  者:史爱武[1] 

机构地区:[1]南京医科大学附属南京妇幼保健院内科,江苏南京210004

出  处:《河北中医》2015年第6期829-831,共3页Hebei Journal of Traditional Chinese Medicine

摘  要:目的观察血压平颗粒治疗妊娠高血压疾病(PIH)的临床疗效。方法将40例PIH患者随机分为2组,对照组20例予盐酸拉贝洛尔治疗,治疗组20例在对照组治疗基础上加血压平颗粒,2组均2周为1个疗程,治疗2个疗程。观察2组患者治疗前后收缩压、舒张压及心率变化情况,盐酸拉贝洛尔用量情况,比较临床疗效。结果治疗组总有效率(95%)与对照组(90%)比较差异无统计学意义(P>0.05),2组疗效相当;治疗组盐酸拉贝洛尔用量增加率低于对照组,但比较差异无统计学意义(P>0.05)。2组治疗后收缩压、舒张压及心率均较本组治疗前下降(P<0.01,P<0.05),且治疗组低于对照组(P<0.05)。结论血压平颗粒治疗PIH能有效降低血压,安全、有效,值得临床推广使用。Objective To observe the clinical effects of Xueyaping granules on pregnancy -induced hy-pertension (PIH).Methods 40 PIH patients were randomly divided into two groups .20 patients in control group were treated by labetalol hydrochloride tablets .20 patients in treatment group were treated by Xueyaping granules on the basis of control group treatment .The treatment course was two weeks in two groups .The systolic pressure,dias-tolic pressure,heart rate and dosage of labetalol hydrochloride tablets were observed before and after two treatment courses,and the clinical effects were compared .Results There was no significant difference between treatment group (95%) and control group (90%) on the total effective rate (P 〈0.05).The dosage increase rate of labetalol hydrochloride tablets in treatment group was lower than that in control group ,but there was no significant difference (P 〈0.05).The systolic pressure,diastolic pressure and heart rate after treatment were decreased in two group (P 〈0.01,P 〈0.05),and the decrease in treatment group was lower than that in control group (P 〈0.05).Conclusion Xueyaping granules can effectively reduce blood pressure ,has a safe and effective effect on pregnancy -induced hypertension,worthy clinical promotion.

关 键 词:高血压 妊娠性 降压药(中药) 中医疗法 

分 类 号:R714.246[医药卫生—妇产科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象